As of now, there are no FDA-approved miRNA-based therapies for cancer. However, several miRNA-targeted therapies are in various stages of clinical trials. These include miRNA mimics and antagomiRs (anti-miRNA oligonucleotides) designed to modulate the expression of specific miRNAs involved in cancer progression.